We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Researchers Stress Cancer Cells for Better Treatment Options

By LabMedica International staff writers
Posted on 10 Dec 2014
Employing metabolic stress to destroy cancer cells could create new approaches for better targeted therapies that will not hurt normal cells and have no unpleasant side effects.

Researchers from the University of Adelaide in South Australia (Adelaide) revealed that chromosomal instability, which is a major characteristic of quickly dividing cancer cells, makes them stressed and susceptible to mild metabolic disruption.

Metabolism is the normal process by which the body converts food into energy. “A common problem in treating cancers is that they don’t respond to chemotherapy, or they respond for a while, but then come back,” stated lead author Dr. Stephen Gregory, senior postdoctoral fellow with the University’s School of Molecular and Biomedical Sciences.

“One reason this happens is because a tumor is usually not made up of identical cells but rather a diverse population of cells that changes all the time, losing, and gaining chromosomes as they divide—so-called chromosomal instability. Sooner or later they change enough to be able to resist chemotherapy drugs. Our research has shown that chromosomal instability has some consequences for cells—they get stressed, and it only takes a small metabolic push to kill them.”

Traditional chemotherapy is also very toxic to all dividing cells, especially affecting cells in hair follicles, blood, and the gut lining, frequently causing hair loss, pain, and making patients unwell. “We need to find ways to target cancer cells without affecting other normal dividing cells,” said Dr. Gregory.

The researchers stimulated chromosomal instability in the fly Drosophila and discovered that the unstable cells were “on the edge” of how much stress they could endure. “This is significant because a change in metabolism is something people cope with very well normally,” said Dr. Gregory. “That means that we hope to be able to develop treatments that have no side effects on patients, but are able to kill off the unstable tumor cells that cause relapses.”

Dr. Gregory noted that this may give some support to hypotheses of alternative treatments such as going on a drastic diet. “People who have advanced cancer which isn’t responding to chemotherapy often try a range of different treatments such as a radical diet in the hope it may help,” he said. “In some situations, it may in fact work; but we hope to be able to point the way to a more targeted approach—finding the most appropriate steps for intervention in the metabolic process that will give the best results.”

The research was published October 27, 2014, in the journal Oncogene.

Related Links:

University of Adelaide in South Australia


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more